Craig Gordon

Craig Gordon, MD, is a licensed physician with over a decade of buy-side experience managing global biopharmaceutical portfolios. In September 2021, he launched GordonMD Global Investments. The firm is focused on investments in private and publicly traded global growth and innovative biopharma companies primarily located in the US, Japan, and Europe. GordonMD Global Investments stands apart from other equity managers, including those focused on biopharmaceutical or similar sectors and industries. The firm’s perspective is derived from Dr. Gordon’s medical knowledge and training combined with his over 10 years of experience at The Capital Group, where he served as an Equity Investment Analyst, built and managed an on average over $7 billion AUM portfolio across various mandates, and assisted with oversight of additional multibillion-dollar AUM portfolios. Prior to establishing his own firm, Dr. Gordon worked at The Capital Group for 10+ years, where he was an Equity Investment Analyst and built his own portfolio and established a successful track record in private placements and with multiple fund mandates, including US growth, global growth, and small-cap. Prior to The Capital Group, he worked for the Cowen Group in New York as a Biotechnology Equity Research Analyst and Associate. Dr. Gordon lives and works in Los Angeles but frequently visits management teams and attends conferences across the world.

He earned a Master of Business Administration degree from Duke University, a Doctor of Medicine from the University of Miami Miller School of Medicine, and a Bachelor of Arts degree in Economics from Cornell University.